Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced MelanomaAntoni Ribas, Caroline Robert, Wen-Jen Hwu et al.|JAMA|2016Cited by 1.1k
P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanomaAntoni Ribas, F. Stephen Hodi, Jedd D. Wolchok et al.|European Journal of Cancer|2015Cited by 34
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing SchedulesCaroline Robert, Omid Hamid, Anthony M. Joshua et al.|Annals of Oncology|2014Cited by 23
Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001.Caroline Robert, Antoni Ribas, Anthony M. Joshua et al.|Journal of Clinical Oncology|2015Cited by 15